1. Home
  2. TARS vs SAH Comparison

TARS vs SAH Comparison

Compare TARS & SAH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TARS
  • SAH
  • Stock Information
  • Founded
  • TARS 2016
  • SAH 1997
  • Country
  • TARS United States
  • SAH United States
  • Employees
  • TARS N/A
  • SAH N/A
  • Industry
  • TARS Medicinal Chemicals and Botanical Products
  • SAH Other Specialty Stores
  • Sector
  • TARS Health Care
  • SAH Consumer Discretionary
  • Exchange
  • TARS Nasdaq
  • SAH Nasdaq
  • Market Cap
  • TARS 2.8B
  • SAH 2.8B
  • IPO Year
  • TARS 2020
  • SAH 1997
  • Fundamental
  • Price
  • TARS $77.39
  • SAH $61.55
  • Analyst Decision
  • TARS Strong Buy
  • SAH Buy
  • Analyst Count
  • TARS 7
  • SAH 9
  • Target Price
  • TARS $69.86
  • SAH $80.00
  • AVG Volume (30 Days)
  • TARS 461.9K
  • SAH 261.5K
  • Earning Date
  • TARS 11-04-2025
  • SAH 10-23-2025
  • Dividend Yield
  • TARS N/A
  • SAH 2.47%
  • EPS Growth
  • TARS N/A
  • SAH N/A
  • EPS
  • TARS N/A
  • SAH 3.73
  • Revenue
  • TARS $366,100,000.00
  • SAH $15,178,100,000.00
  • Revenue This Year
  • TARS $139.46
  • SAH $7.11
  • Revenue Next Year
  • TARS $49.91
  • SAH $3.64
  • P/E Ratio
  • TARS N/A
  • SAH $16.48
  • Revenue Growth
  • TARS 182.44
  • SAH 9.09
  • 52 Week Low
  • TARS $38.51
  • SAH $52.00
  • 52 Week High
  • TARS $78.76
  • SAH $89.62
  • Technical
  • Relative Strength Index (RSI)
  • TARS 66.65
  • SAH 36.97
  • Support Level
  • TARS $70.84
  • SAH $60.50
  • Resistance Level
  • TARS $78.76
  • SAH $64.88
  • Average True Range (ATR)
  • TARS 3.29
  • SAH 1.77
  • MACD
  • TARS 0.35
  • SAH 0.39
  • Stochastic Oscillator
  • TARS 88.54
  • SAH 50.32

About TARS Tarsus Pharmaceuticals Inc.

Tarsus Pharmaceuticals Inc is a commercial-stage biopharmaceutical company focused on the development and commercialization of therapeutics, starting with eye care. The company is focused on the development and commercialization of first-in-class therapeutic candidates to provide treatment for ophthalmic conditions. The company's candidate XDEMVY is a novel investigational eye drop to treat blepharitis caused by the infestation of Demodex mites, referred to as Demodex blepharitis.

About SAH Sonic Automotive Inc.

Sonic Automotive is one of the largest auto dealership groups in the United States. The company has 108 franchised stores in 18 states, primarily in metropolitan areas in California, Texas, and the Southeast, plus 18 EchoPark used-vehicle stores, 16 collision centers, and 14 powersports locations. The franchise stores derive revenue from new and used vehicles plus parts and collision repair, finance, insurance, and wholesale auctions. Luxury and import dealerships make up about 86% of franchise new-vehicle revenue, while Honda, BMW, Mercedes, and Toyota constitute about 59% of new-vehicle revenue. BMW is the largest brand at about 25%. 2024's revenue was $14.2 billion, with Texas and California comprising 51% of the total. EchoPark's portion was $2.1 billion.

Share on Social Networks: